제12권 2호
REVIEW ARTICLE중추신경계 작용 약물 중심의 비만 치료 전략
- Jang Won Son, MD, PhD
- Journal of Multiple Sclerosis and Neuroimmunology 12(2):25-34, 2021
시신경척수염 환자에서 리툭시맙 반복 투여 후 발생한 지연성 B형 간염의 재활성화
- Hyesun Lee, MD, Euihyun Sung, MD, Wonjae Sung, MD, Seung Hyun Kim, MD, PhD
- Journal of Multiple Sclerosis and Neuroimmunology 12(2):35-38, 2021
리툭시맙에 치료효과를 보인 만성염증탈수초다발신경병
- Dayoung Kim, MD, Kyomin Choi, MD, Jeeyoung Oh, MD, PhD
- Journal of Multiple Sclerosis and Neuroimmunology 12(2):39-42, 2021
Cyclophosphamide로 치료된 재발 특발비후경수막염
- Hyunjong Eom, MD, Min Kyung Kim, MD, Ji Hye Shin, MD, Ji Hyun Kim, MD, PhD
- Journal of Multiple Sclerosis and Neuroimmunology 12(2):43-46, 2021
척수 지주막염 이후 발생한 다발성 뇌신경병증과 항-강글리오사이드항체
- Seung Jae Kim, MD, Wonjae Sung, MD, Young Seo Kim, MD
- Journal of Multiple Sclerosis and Neuroimmunology 12(2):47-50, 2021
Gerstmann증후군을 보인 항N-Methyl-D-Aspartate뇌염
- Hyunkee Kim, MD, MM, Jinseok Park, MD, PhD, Hee-Jin Kim, MD, PhD
- Journal of Multiple Sclerosis and Neuroimmunology 12(2):51-54, 2021
임상적으로 의심된 면역글로불린 G4 연관 질환에 의한 다발성 뇌신경마비
- Jaewoon Chung, MD, Jihyun Kim, MD, Jungsoo Lee, MD, Saemi Choi, MD, Hyun Young Kim, MD, PhD, Sanggon Lee, MD, MSc
- Journal of Multiple Sclerosis and Neuroimmunology 12(2):55-59, 2021
전신홍반루푸스 환자에서 경구 면역억제제 증량 후 발생한 진행성다초점백질뇌병증
- Ilmo Kang, MD, Sanggon Lee, MD, MSc
- Journal of Multiple Sclerosis and Neuroimmunology 12(2):60-63, 2021